In a groundbreaking study shedding light on the molecular intricacies of arousal regulation, researchers from Pompeu Fabra University (UPF) and the Centre for Genomic Regulation (CRG) have unveiled the profound influence of neuronal microexons on behavioral states in zebrafish. This study elucidates how subtle alterations in these tiny genetic fragments can trigger hyperarousal—a state marked by heightened neural excitability and pronounced insomnia-like symptoms—which echoes the pathophysiological features observed in various neurodevelopmental disorders. The implications extend far beyond aquatic models, offering a window into the conserved mechanisms of arousal that potentially inform conditions such as autism spectrum disorder and schizophrenia in humans.
Arousal represents a fundamental neurophysiological process essential for survival, enabling organisms to respond to external and internal stimuli with appropriate behavioral and neural adaptations. This highly conserved mechanism across species ensures a meticulously balanced state, modulating responsiveness between lethargy and sensory hypersensitivity. Dysregulation of this balance manifests clinically as either diminished responsiveness or excessive wakefulness and sensory overload, typical hallmarks of stress and various neurodevelopmental pathologies.
Fundamental to this regulatory system is the diversity of proteins synthesized during development and adulthood through alternative splicing—a sophisticated post-transcriptional gene editing process. Alternative splicing enables the generation of multiple functionally distinct protein isoforms from a single gene, often mediated by the inclusion or exclusion of microexons. Microexons are exceptionally short exonic sequences within neuronal genes that profoundly influence protein function and neuronal circuit dynamics despite their minuscule size.
The investigative team employed zebrafish larvae, leveraging their optical transparency and genetic tractability to scrutinize the behavioral consequences of neural microexon misregulation. Larvae exhibiting abnormal microexon patterns demonstrated conspicuous hyperarousal behaviors including disrupted swim patterns and shortened sleep duration. “These larvae not only sleep less frequently but also take considerably longer to initiate sleep,” remarks first author Tahnee Mackensen. This behavioral hyperactivity parallels neural hyperexcitability, suggesting microexon regulation as a pivotal determinant of neurobehavioral states.
At the cellular signaling level, the researchers identified dysregulated cyclic adenosine monophosphate (cAMP) cascades as a key mediator of the observed hyperactive state. cAMP is a ubiquitous second messenger involved in modulating neuronal excitability and synaptic plasticity. The altered splicing of microexons modulates cAMP synthesis and degradation pathways, leading to an aberrant excitation of forebrain neurons in hyperaroused larvae. Notably, this altered cAMP signaling manifests as heightened cAMP-dependent protein kinase A (PKA) activity and subsequent phosphorylation of the transcription factor CREB, implicating the canonical cAMP-PKA-CREB pathway in the regulation of arousal.
The study’s pharmacological interventions underscore the centrality of cAMP regulation in arousal control. Application of cAMP inhibitors normalized the elevated neural activity and behavioral hyperarousal in mutant fish, whereas artificially elevating cAMP in wild-type fish recapitulated the hyperactive phenotype. This bidirectional modulation fortifies the concept that neuronal cAMP levels function as a ‘thermostat’ for arousal states, fine-tuning neuronal excitability and behavioral responsiveness.
Beyond the immediate findings in zebrafish, this research builds upon prior observations in drosophila models demonstrating that microexon disruption similarly impairs sleep and elevates arousal. “The parallel between species indicates an evolutionarily conserved arousal mechanism,” explains Manuel Irimia, senior author. This conservation implies that microexon misregulation, while mechanistically nuanced, may contribute to the neuropsychiatric symptomatology observed in mammals, including humans.
Human neurological disorders such as autism and schizophrenia are often accompanied by sleep disruption and sensory processing anomalies attributed, in part, to aberrant microexon splicing. While microexon alterations are unlikely to be sole causative factors, they may exacerbate or modulate disease phenotypes by disturbing neural excitability homeostasis. These insights prompt a reevaluation of therapeutic strategies aimed at restoring microexon splicing fidelity or modulating cAMP signaling pathways to alleviate neurodevelopmental symptomatology.
Moreover, the link between this microexon-cAMP pathway and mood disorders such as anxiety and depression opens compelling avenues for future research. The cAMP-PKA-CREB axis has well-documented roles in synaptic plasticity and mood regulation, suggesting that microexon-associated dysregulation could contribute to broader neuropsychiatric conditions. “This discovery might just scratch the surface of a complex regulatory network influencing brain function,” notes Mackensen.
The transparency and genetic accessibility of the zebrafish model provided unparalleled opportunities to visualize and quantify internal states through behavioral readouts. Advanced imaging of larval swimming patterns and direct measurement of neurochemical parameters furnished robust correlative evidence linking genetic alterations to functional outcomes. These technical advancements highlight the integrative power of model organisms in neuroscience.
Importantly, this research received support from an array of prestigious funding bodies, including the Horizon 2020 Framework Programme, the Marie Sklodowska-Curie Actions, and the Wellcome Trust, emphasizing the global significance and collaborative nature of this work. The study’s publication in Science Advances confirms its high impact and relevance to the scientific community.
As the team pursues translational studies, the prospect of correcting arousal imbalances by manipulating cAMP pathways or restoring microexon expression presents a promising frontier. This is especially critical given that aberrant arousal and sleep disturbances profoundly impair quality of life in neurodevelopmental disorders. The findings pave the way for multidisciplinary approaches integrating molecular genetics, neurobiology, and pharmacology to develop targeted interventions.
In summation, the identification of neuronal microexons as key modulators of arousal states via the cAMP-PKA-CREB pathway in zebrafish represents a seminal advance in our understanding of the molecular substrates governing complex behavioral phenotypes. This research not only deciphers fundamental biological mechanisms but also holds translational potential to inform therapeutic avenues for neuropsychiatric conditions marked by disrupted arousal and sleep.
Subject of Research: Animals
Article Title: Neuronal microexons modulate arousal via the cAMP-PKA-CREB pathway in zebrafish
News Publication Date: 19-Jun-2026
Web References: 10.1126/sciadv.ady8291
Image Credits: UPF – CRG
Keywords: Exons, Gene splicing, Developmental neuroscience, Anxiety, Sleep disorders, cAMP signaling, Zebrafish
